Arthritis Supplements Depend on the Type of Arthritis

None of the supplements reviewed here has been shown reliably to rebuild cartilage or cure arthritis. For osteoarthritis, a few products have produced possible symptom improvements, but the evidence is inconsistent or too limited to make them dependable treatments. For rheumatoid arthritis, omega-3s may modestly complement medical treatment, but supplements cannot replace medicines that slow joint damage.

The first buying decision is therefore not which supplement? It is which type of arthritis, in which joint, and what outcome am I trying to improve? Evidence from a short knee-osteoarthritis pain trial does not establish a treatment for rheumatoid arthritis, hip arthritis or cartilage loss.

Evidence at a glance

Supplement	What the evidence suggests	Practical verdict
MSM	Small, short knee-osteoarthritis trials suggest possible symptom improvement; clinical importance and long-term safety remain uncertain.	An experimental option for symptom relief, not a proven cartilage treatment.
Turmeric/curcumin	Early results for knee pain and function are positive, but products and absorption-enhancing formulas differ substantially.	Promising but formulation-dependent; liver risk matters.
Glucosamine	Large evidence reviews are inconsistent, and US guidelines disagree. Better-quality evidence has not shown an important benefit reliably.	Do not assume a retail product matches a favorable prescription-formulation study.
Chondroitin	Results vary by preparation and joint. One guideline makes a limited exception for hand osteoarthritis.	Evidence for knee or hip osteoarthritis is not persuasive enough for a confident recommendation.
Omega-3/fish oil	May modestly help rheumatoid-arthritis symptoms as an addition to drug therapy; evidence does not support it well for osteoarthritis.	Arthritis type changes the answer. Never substitute it for rheumatoid-arthritis medication.
Vitamin D	Correcting a deficiency supports bone health, but trials do not show reliable osteoarthritis pain relief.	Address nutritional need, not “arthritis” in general.

MSM: a signal, not a settled result

MSM, or methylsulfonylmethane, has been tested mainly for knee osteoarthritis. In one randomized, double-blind trial, 50 adults with radiographically confirmed knee osteoarthritis were assigned to placebo or 3.375 grams of MSM daily for 12 weeks. One participant did not complete the final WOMAC questionnaire. Physical function and the aggregate WOMAC symptom score favored MSM, but WOMAC pain, stiffness and several secondary outcomes did not differ significantly. The investigators concluded that the improvements were small and might not be clinically meaningful (BMC Complementary Medicine and Therapies).

That trial tells us about one dose, one oral product, one 12-week period and one small knee-osteoarthritis population. It does not prove that MSM prevents joint damage, works for every painful joint or treats inflammatory arthritis. The National Center for Complementary and Integrative Health (NCCIH) likewise says that too little research has been conducted to conclude whether MSM helps osteoarthritis (NCCIH).

Readers considering it can review the wider set of MSM use claims and study doses. A trial dose is not a personalized recommendation; the separate MSM dose-limit review examines the distinction between studied doses and safe-use limits.

MSM is also not interchangeable with DMSO. MSM is sold as an oral dietary supplement, while DMSO is a different substance generally used topically. Evidence for one cannot be transferred to the other.

Turmeric: encouraging results with a formulation problem

Several meta-analyses report initial positive findings for oral turmeric or curcumin on knee-osteoarthritis pain, stiffness or function. NCCIH stops short of a firm conclusion because higher-quality studies are still needed and products vary in curcumin content and bioavailability (NCCIH).

That variation is not a technical footnote. A study of a defined curcumin extract does not validate every turmeric capsule, and adding piperine or using another absorption-enhancing system changes exposure. Highly bioavailable curcumin formulations have also been associated with liver injury. Anyone with liver disease, unexplained abnormal liver tests or medicines that could interact with an herbal product should discuss the specific formula with a clinician or pharmacist.

Glucosamine and chondroitin: why recommendations conflict

Glucosamine and chondroitin have more osteoarthritis research than MSM, yet the answer is not clearer. The 2019 American College of Rheumatology/Arthritis Foundation (ACR/AF) guideline recommends strongly against glucosamine for hand, knee and hip osteoarthritis and against chondroitin for knee or hip osteoarthritis. It conditionally recommends chondroitin for hand osteoarthritis. By contrast, the 2021 American Academy of Orthopaedic Surgeons (AAOS) guideline includes glucosamine and chondroitin among supplements that may help mild-to-moderate knee osteoarthritis, while describing the evidence as limited and inconsistent (NCCIH).

The disagreement reflects different evidence judgments, not proof that every position is equally strong. ACR/AF concluded that the glucosamine trials with the lowest risk of bias did not show important benefit over placebo. It also recommended against glucosamine-chondroitin combination products for knee and hip osteoarthritis (ACR/AF guideline).

Product identity further complicates comparisons: glucosamine sulfate is not glucosamine hydrochloride, and a standardized pharmaceutical preparation studied in another country is not automatically equivalent to a US retail supplement. Combination labels make attribution harder still. Our glucosamine, chondroitin and MSM evidence review separates the ingredients rather than treating the blend as one proven intervention.

Omega-3: potentially relevant to rheumatoid arthritis, not a substitute for treatment

Rheumatoid arthritis is an immune-mediated inflammatory disease, not another name for osteoarthritis. NCCIH reports that a 2022 review of 30 studies involving 1,420 participants found that diets rich in polyunsaturated fatty acids—especially omega-3s—may improve pain and swollen or tender joints when added to rheumatoid-arthritis drug therapy. A second review found lower pain but rated the evidence low (NCCIH).

That supports only a possible adjunctive role. Conventional rheumatoid-arthritis treatment can slow joint damage; fish oil cannot be assumed to do so. The ACR/AF osteoarthritis guideline, meanwhile, conditionally recommends against fish oil for hand, hip and knee osteoarthritis because the relevant evidence was inadequate (ACR/AF guideline).

Vitamin D: correct deficiency for its own reason

Vitamin D promotes calcium absorption and supports normal bone mineralization, but “supports bones” does not mean “relieves arthritis.” The ACR/AF guideline conditionally recommends against vitamin D as an osteoarthritis treatment because pooled trial results were null. Vitamin D may still be appropriate when a person’s intake, clinical circumstances or blood level indicates a nutritional need; that is a separate bone-health decision. Excessive supplemental vitamin D can cause toxicity, so more is not automatically better (NIH Office of Dietary Supplements).

How to evaluate an arthritis supplement without overreading the label

1. Confirm the diagnosis and joint. Evidence for knee osteoarthritis does not establish benefit for rheumatoid arthritis, gout, an injured tendon or unexplained joint swelling.
2. Choose the outcome in advance. A reasonable test asks whether pain or function changes. “Joint support,” “anti-inflammatory” and “cartilage nourishment” are not measurable clinical outcomes.
3. Match the product to the study. Check the ingredient form, amount per daily serving, additional ingredients and delivery route. A proprietary blend may prevent a useful dose comparison.
4. Prefer one new ingredient at a time. A multi-ingredient formula makes it difficult to tell what helped or caused a side effect. Single-ingredient MSM and combination products involve different trade-offs.
5. Set a stop rule. Do not keep paying indefinitely for a product that produces no meaningful, trackable improvement over a time frame relevant to the study.
6. Check medicines and conditions first. Glucosamine and chondroitin have been associated with increased bleeding risk in people taking warfarin; turmeric formulas can affect the liver or interact with medicines; omega-3 products can cause gastrointestinal effects. Pregnancy, planned surgery, liver or kidney disease, anticoagulant use and multiple medications are reasons to have a clinician or pharmacist review the specific product.
7. Treat quality certification as a manufacturing check, not proof of benefit. In the United States, FDA does not approve dietary supplements for safety or effectiveness before marketing. Manufacturers and distributors initially bear responsibility for compliance, while much FDA enforcement occurs after products reach the market (FDA). Look for a complete Supplement Facts panel, lot information and credible independent testing, but do not mistake a purity mark for clinical evidence.

A supplement trial should follow diagnosis and established care, not delay them. A new hot or markedly swollen joint, fever, sudden inability to bear weight, or persistent morning stiffness across several joints calls for medical assessment rather than another supplement purchase.